These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 15266063

  • 1. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP.
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
    Sugano M, Shintani Y, Kobayashi K, Sakakibara N, Isomura I, Morita A.
    J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
    [Abstract] [Full Text] [Related]

  • 3. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A, Gambichler T, Breuckmann F, Pawlak FM, Stücker M, Bader A, Altmeyer P, Freitag M.
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [Abstract] [Full Text] [Related]

  • 4. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
    Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F.
    Eur J Dermatol; 2002 Sep; 12(1):50-2. PubMed ID: 11809595
    [Abstract] [Full Text] [Related]

  • 5. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus.
    Tlacuilo-Parra A, Guevara-Gutiérrez E, Gutiérrez-Murillo F, Soto-Ortiz A, Barba-Gómez F, Hernández-Torres M, Salazar-Páramo M.
    Rheumatology (Oxford); 2005 Dec; 44(12):1564-8. PubMed ID: 16159951
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
    Madan V, August PJ, Chalmers RJ.
    Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
    [Abstract] [Full Text] [Related]

  • 7. A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index.
    Pothinamthong P, Janjumratsang P.
    J Med Assoc Thai; 2012 Jul; 95(7):933-40. PubMed ID: 22919989
    [Abstract] [Full Text] [Related]

  • 8. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML, McCauliffe DP.
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [Abstract] [Full Text] [Related]

  • 9. The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
    Wollina U, Hansel G.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):1-6. PubMed ID: 18005117
    [Abstract] [Full Text] [Related]

  • 10. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW, Sontheimer RD.
    Am J Clin Dermatol; 2009 Jan; 10(6):365-81. PubMed ID: 19824738
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C.
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [Abstract] [Full Text] [Related]

  • 12. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
    Raptopoulou A, Linardakis C, Sidiropoulos P, Kritikos HD, Boumpas DT.
    Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.
    Kreuter A, Tomi NS, Weiner SM, Huger M, Altmeyer P, Gambichler T.
    Br J Dermatol; 2007 Jun; 156(6):1321-7. PubMed ID: 17408395
    [Abstract] [Full Text] [Related]

  • 14. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
    Ordi-Ros J, Cortés F, Cucurull E, Mauri M, Buján S, Vilardell M.
    J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
    [Abstract] [Full Text] [Related]

  • 15. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA, Mbuagbaw J, Burge SM.
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [Abstract] [Full Text] [Related]

  • 16. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
    Ruzicka T, Meurer M, Bieber T.
    Arch Dermatol; 1988 Jun; 124(6):897-902. PubMed ID: 2967674
    [Abstract] [Full Text] [Related]

  • 17. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR, Crosby D.
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [Abstract] [Full Text] [Related]

  • 18. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.
    Barikbin B, Givrad S, Yousefi M, Eskandari F.
    Clin Exp Dermatol; 2009 Oct; 34(7):776-80. PubMed ID: 19456797
    [Abstract] [Full Text] [Related]

  • 19. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG, Kouvelas D.
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [Abstract] [Full Text] [Related]

  • 20. Drug-induced lupus erythematosus.
    Marzano AV, Tavecchio S, Menicanti C, Crosti C.
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.